| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 10-Q/A |
| 06 Nov 2026 | 10-Q |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 |
8-K: Other Events
MINNEAPOLIS, November 3, 2026/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2026. The quarterly dividend wi... |
| 03 Nov 2026 |
Form 4: Kelderman Kim, Director
Gave up 2,385 shares to cover exercise price or tax ($173K) |
| 03 Nov 2026 |
Form 4: Hippel James, CFO
Received 11,545 shares by exercise or conversion · Gave up 5,096 shares to cover exercise price or tax ($370K) |
| 02 Nov 2026 |
Form 4/A: Hippel James, CFO
Received 9,980 shares by exercise or conversion · Gave up 4,423 shares to cover exercise price or tax ($320K) · Disposed of 34,443 Performance Stock Options (Right to Buy) (Disposition to Issuer) · 1 more |
| 02 Nov 2026 |
Form 4/A: Geist William, PRESIDENT, PROTEIN SCIENCES
Received 6,547 shares by exercise or conversion · Gave up 2,019 shares to cover exercise price or tax ($146K) · Disposed of 22,545 Performance Stock Options (Right to Buy) (Disposition to Issuer) · 1 more |
| 02 Nov 2026 |
Form 4/A: Kelderman Kim, Director
Received 21,736 shares by exercise or conversion · Gave up 10,955 shares to cover exercise price or tax ($793K) · Disposed of 45,993 Performance Stock Options (Right to Buy) (Disposition to Issuer) · 1 more |
| 02 Nov 2026 |
Form 4/A: Bohnen Shane, SVP - General Counsel
Received 4,420 shares by exercise or conversion · Gave up 1,366 shares to cover exercise price or tax ($98.9K) · Disposed of 11,929 Performance Stock Option (Right to Buy) (Disposition to Issuer) · 1 more |
| 02 Nov 2026 |
Form 4: Vessey Rupert, Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Seth Alpna, Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Klimovsky Judith V., Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Herr Amy E., Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Keegan Joseph D, Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Higgins John L, Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Bushman Julie L, Director
Received 2,750 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Baumgartner Robert V, Director
Received 2,750 shares as a grant or award |
| 28 Oct 2026 | 10-K/A |
| 30 Sep 2026 |
Form 4: Higgins John L, Director
Received 15,940 shares by exercise or conversion · Gave up 5,562 shares to cover exercise price or tax ($403K) |
Loading...